文献速递鼻科小儿耳鼻咽喉

舌下免疫治疗完成情况的预测因素

Predictors of Completion of Sublingual Immunotherapy.
PubMed 文献 · Laryngoscope · 2020-11-12

该研究回顾性分析了2008至2020年接受舌下免疫治疗(SLIT)的404例患者,发现仅11.6%完成至少36个月治疗,61.6%中止。

要点

  • 增加门诊随访频率可显著提高SLIT完成率。
  • 有哮喘史的12岁以下儿童完成率更高。

核心结论

  • 增加门诊随访频率、改善治疗可及性及缓解对临床疗效的担忧可能提高患者SLIT完成率。

研究设计与样本

  • 单中心回顾性队列研究,纳入2008至2020年接受SLIT的患者共404例。

主要发现

  • 404例患者中,249例(61.6%)中止治疗,47例(11.6%)完成治疗,108例(26.7%)仍在治疗中。
  • 中止治疗者的平均治疗时长为11.2个月,完成治疗者为49.4个月。

关键数值与推荐

  • 完成SLIT定义为完成至少36个月的治疗。

临床怎么用

  • 应通过增加随访频率、提高治疗可及性及沟通疗效来提升SLIT完成率。

局限性

  • 本研究为单中心回顾性研究,证据等级为4级。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Sublingual immunotherapy (SLIT) has emerged as an effective treatment alternative to subcutaneous immunotherapy (SCIT) given its improved safety profile and more convenient dosing. However, SLIT still relies on daily dosing for many years to optimize effectiveness. This study sought to investigate factors that influence patient completion of SLIT. METHODS: We performed an institutional retrospective review of patients who received SLIT (2008-2020). Completion was defined as completing at least 36 months of SLIT. Patient demographics and characteristics, including the number of allergens treated, history of asthma and sinus surgery, number of clinic visits, and total time undergoing SLIT, were documented. Multivariate models were used to analyze predictors of SLIT completion. Subgroup analysis was performed among pediatric patients and patients who discontinued SLIT. RESULTS: Of the 404 total patients, 249 (61.6%) discontinued, 47 (11.6%) completed, and 108 (26.7%) were currently undergoing SLIT. The mean duration of therapy was 11.2 months for those who discontinued and 49.4 months for patients who completed SLIT. The odds of SLIT completion were twice as high with each additional clinic visit (P < .001), and twice as high when the dosage was increased during therapy (P = .06). Pediatric patients younger than age 12 with a history of asthma were over five times more likely to complete therapy (P = .045). Patients with more clinic visits (P < .001) and higher associated costs (P = .003) were less likely to be lost to follow-up. CONCLUSION: Increasing the frequency of clinic visits, improving therapy availability, and mitigating concerns about clinical efficacy may increase patient completion of SLIT. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:E2111-E2115, 2021.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Hura N, Song S, Kamil RJ, et al. Predictors of Completion of Sublingual Immunotherapy. Laryngoscope. 2020. PMID: 33179776. doi:10.1002/lary.29272

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。